TY - JOUR T1 - The association between lymphocyte mitochondrial DNA abundance and Stroke: a combination of multivariable-adjusted survival and mendelian randomization analyses JF - medRxiv DO - 10.1101/2021.10.27.21265463 SP - 2021.10.27.21265463 AU - Leon G Martens AU - Jiao Luo AU - Marieke J H Wermer AU - Ko Willems van Dijk AU - Sara Hägg AU - Felix Grassmann AU - Raymond Noordam AU - Diana van Heemst Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/28/2021.10.27.21265463.abstract N2 - Background and Purpose Mitochondrial dysfunction is associated with increased Reactive Oxygen Species that are thought to drive risk of disease, including stroke. We investigated the association between mtDNA abundance, as a proxy for mitochondrial function, and incident stroke using multivariable-adjusted survival and Mendelian Randomization (MR) analyses.Methods Cox-proportional hazard model analyses were conducted to assess the association between lymphocyte mtDNA abundance, and incident ischemic and hemorrhagic stroke over a maximum of 14-years follow-up in unrelated European-ancestry participants from UK Biobank. MR was conducted using independent (R2<0.001) lead variants for lymphocyte mtDNA abundance (p < 5×10-8) as instrumental variables. Single-Nucleotide Polymorphism (SNP)- ischemic stroke associations were derived from three published open source European-ancestry results databases (cases/controls): MEGASTROKE (60,341/454,450), UK Biobank (2,404/368,771) and FinnGen (10,551/202,223). MR was performed per study, and results were subsequently meta-analyzed.Results A total of 288,572 unrelated participants (46% men) with mean (SD) age of 57 (8) years were included in the cox-proportional hazard analyses. After correction for considered confounders (BMI, hypertension, cholesterol, T2D), no association was found between mtDNA abundance and ischemic or hemorrhagic stroke (lowest 20% versus highest 20%: ischemic stroke, hazard ratio, 1.06 [95% confidence interval 0.95, 1.18]; hemorrhagic stroke, hazard ratio 0.97 [95% confidence interval, 0.82, 1.15]). In line, in the MR analyses, we found no evidence for an association between genetically-influenced mtDNA abundance and ischemic stroke (odds ratio, 1.04; confidence interval, 0.95, 1.15).Conclusions From the multivariable-adjusted survival analyses and the MR analyses, we did not find support for low lymphocyte mtDNA abundance as a causal risk factor in the development of stroke.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the VELUX Stiftung (grant number 1156), the China Scholarship Counsel (No. 201808500155), the Dutch Heart Foundation (grant number 2019T103 to R.N.) and the Ake Wibergs Foundation (grant number M19-0294 to F.G).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data from the UK Biobank is available upon acceptance of a research proposal by UK Biobank Recourses and payment of an access fee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsGWASGenome Wide Association StudyHRHazard RatioMRMendelian RandomizationmtDNA-CNmitochondrial DNA Copy NumbersOROdds RatioROSReactive Oxygen SpeciesSNPSingle-Nucleotide Polymorphisms ER -